Current Appointments & Affiliations
Adjunct Associate Professor in the Department of Medicine
·
2020 - Present
Medicine, Cardiology,
Medicine
Recent Publications
Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: 48-Week Results From FOREST-HCM.
Journal Article JACC Heart Fail · June 19, 2025 BACKGROUND: Long-term safety and efficacy data for aficamten in symptomatic obstructive hypertrophic cardiomyopathy are needed. OBJECTIVES: This study aims to evaluate 48-week experience from the ongoing FOREST-HCM (A Follow-Up, Open-Label, Research Evalua ... Full text Link to item CiteConcomitant Aficamten and Disopyramide in Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Journal Article JACC Heart Fail · April 2, 2025 BACKGROUND: Disopyramide, used in obstructive hypertrophic cardiomyopathy (oHCM) for its negative inotropic properties mediated by its reduction in cytosolic calcium, has been recommended for decades as an option to relieve resistant obstruction. Aficamten ... Full text Link to item CiteStandard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM.
Journal Article J Am Coll Cardiol · November 5, 2024 BACKGROUND: Standard-of-care (SoC) medications for the treatment of obstructive hypertrophic cardiomyopathy (oHCM) are recommended as first-line therapy despite the lack of evidence from controlled clinical trials and well known off-target side effects. OB ... Full text Link to item CiteRecent Grants
PTN2- TO# BPCA Pharmacology Studies
ResearchPanel Member · Awarded by National Institute for Child Health & Human Develo · 2018 - 2023PTN_TO#50 POPS LAB
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2022Heart Failure Network: Year 12 Non-Compete Renewal
Clinical TrialMedical Monitor · Awarded by National Institutes of Health · 2006 - 2021View All Grants
Education, Training & Certifications
University of Bologna (Italy) ·
1999
M.D.